In vitro anti-neuroblastoma activity of saquinavir and its association with imatinib
- PMID: 22159894
- DOI: 10.3892/or.2011.1582
In vitro anti-neuroblastoma activity of saquinavir and its association with imatinib
Abstract
Neuroblastoma (NB) has a poor prognosis when in advanced stages, highlighting the need for new therapeutic options. The human immunodeficiency virus (HIV) protease inhibitor saquinavir is active in vitro against chronic myeloid leukaemia cells, in synergy with the tyrosine kinase inhibitor imatinib. Here, we evaluated the effects of saquinavir, alone or in association with imatinib, on cell proliferation (count of viable cells after trypan blue exclusion), apoptosis (Annexin V binding) and invasion (through a transwell membrane coated with Matrigel) in SJ-N-KP, IMR5, AF-8, SK-N-SH and SK-N-BE NB lines, all expressing c-kit and PDGF-R (determined by flow cytometry). Saquinavir showed a dose-dependent anti-proliferative and anti-invasive activity on NB lines, increased by the association with imatinib when the two drugs were utilized at clinically attainable concentrations. The same low saquinavir concentrations inhibited in NB cells the nuclear activation of NF-κB (Western immuno-blotting for nuclear NF-κB p50 and p65). Saquinavir at high concentrations also exerted a pro-apoptotic activity on NB lines, significantly increased by the association with imatinib. In conclusion, saquinavir and imatinib are both drugs utilized for long-term therapies, with good oral bioavailability and a well-known toxicity profile. The anti-NB activity of saquinavir and of its association with imatinib suggests a potential usefulness in the treatment of NB, particularly for remission maintenance.
Similar articles
-
In vitro antiproliferative and antimigratory activity of dasatinib in neuroblastoma and Ewing sarcoma cell lines.Oncol Rep. 2008 Feb;19(2):353-9. Oncol Rep. 2008. PMID: 18202781
-
The effects of saquinavir on imatinib-resistant chronic myelogenous leukemia cell lines.Haematologica. 2006 May;91(5):711-2. Haematologica. 2006. PMID: 16670078
-
The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells.Cancer Res. 2002 Sep 15;62(18):5230-5. Cancer Res. 2002. PMID: 12234989
-
Effect of STI-571 (imatinib mesylate) in combination with retinoic acid and gamma-irradiation on viability of neuroblastoma cells.Biochem Biophys Res Commun. 2006 Apr 21;342(4):1405-12. doi: 10.1016/j.bbrc.2006.02.059. Epub 2006 Feb 21. Biochem Biophys Res Commun. 2006. PMID: 16524560
-
[Expression of c-kit and PDGFR and possibility of tyrosine kinase inhibitor employment in treatment of neuroblastoma in children].Przegl Lek. 2010;67(6):413-6. Przegl Lek. 2010. PMID: 21344772 Review. Polish.
Cited by
-
The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies.Int J Mol Sci. 2018 May 9;19(5):1418. doi: 10.3390/ijms19051418. Int J Mol Sci. 2018. PMID: 29747434 Free PMC article. Review.
-
Two Novel Precursors of the HIV-1 Protease Inhibitor Darunavir Target the UPR/Proteasome System in Human Hepatocellular Carcinoma Cell Line HepG2.Cells. 2021 Nov 6;10(11):3052. doi: 10.3390/cells10113052. Cells. 2021. PMID: 34831275 Free PMC article.
-
Repurposing Alone and in Combination of the Antiviral Saquinavir with 5-Fluorouracil in Prostate and Lung Cancer Cells.Int J Mol Sci. 2022 Oct 13;23(20):12240. doi: 10.3390/ijms232012240. Int J Mol Sci. 2022. PMID: 36293096 Free PMC article.
-
Use of Antiangiogenic Therapies in Pediatric Solid Tumors.Cancers (Basel). 2021 Jan 12;13(2):253. doi: 10.3390/cancers13020253. Cancers (Basel). 2021. PMID: 33445470 Free PMC article. Review.
-
Saquinavir: From HIV to COVID-19 and Cancer Treatment.Biomolecules. 2022 Jul 5;12(7):944. doi: 10.3390/biom12070944. Biomolecules. 2022. PMID: 35883499 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous